Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the team provides one of the ...
Apr 27, 2026
0
4
Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune system's first line of defense. NK cells can detect and destroy cancer cells, but tumors often create ...
Apr 27, 2026
0
10
Machine learning models can predict the risk for developing moderate-to-severe persistent asthma and allergic rhinitis in children diagnosed with early-life atopic dermatitis, according to a study published online April 17 ...
Apr 25, 2026
0
4
Every day, thousands of people worldwide suffer a heart attack, often leading to lasting damage to the heart muscle. Recent research from the University of Oslo suggests that targeting inflammation in the body helps protect ...
Apr 22, 2026
0
7
People might not associate brain fog and fatigue with spring allergies, but these symptoms can make life just as miserable—or sometimes more—than the watery eyes, itchy noses, and congestion we typically associate with reactions ...
Apr 22, 2026
0
7
Researchers at McGill University have found that briefly treating peanuts with cold plasma, an ionically charged gas that triggers chemical changes, reduces their potential to cause allergic reactions. The researchers say ...
Apr 22, 2026
0
5
A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma tumors may help researchers better understand which patients will benefit from combination immunotherapy ...
Apr 22, 2026
0
3
Knowing that women are diagnosed with multiple sclerosis (MS) at three times the rate of men, particularly during their 30s and 40s, scientists in the CU Anschutz lab of Kimberley Bruce, Ph.D., recently took that window of ...
Apr 21, 2026
0
3
A type of rare T cell triggers a cascade of signals amplifying inflammation and ultimately leading to liver fibrosis, according to a new study from Julius Maximilian University of Würzburg published in Nature Communications. ...
Apr 21, 2026
0
2
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in patients who experienced ...
Apr 21, 2026
0
4
